Citizens analyst Jonathan Wolleben raised the price target on Spruce Biosciences, Inc. (NASDAQ: SPRB) to $259.00 (from $254.00) while maintaining ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE